tbuckley/cabot-search huggingface dataset:
Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin
Authors: Patrick Blaney, Eileen M Boyle, Kylee H Maclachlan, Louis S. Williams, Dylan Gagler, Parvathi Sudha, Alexandra M Poos, Yubao Wang, Hussein Ghamlouch, Avital Tenenbaum, Ariel Siegel, Xiaoyi Chen, Gaurav Varma, David Kaminetzsky, Marc Braunstein, David Coffey, Benjamin Diamond, Bachisio Ziccheddu, Dickran Kazandjian, Urvi A Shah, Elizabeth E. Brown, Elisabet E. Manasanch, Alexander M Lesokhin, Niels Weinhold, Brian A. Walker, Saad Usmani, Ola Landgren, Faith E Davies, Francesco Maura, Gareth J. Morgan
Journal: Blood (2022)
Impact of Additional Intensive L-Asparaginase Therapy during Consolidation Phase for High-Risk Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial in the AIEOP-BFM ALL 2009 Protocol
Authors: Valentino Conter, Maria Grazia Valsecchi, Gunnar Cario, Martin Zimmermann, Andishe Attarbaschi, Jan Stary, Felix Niggli, Luciano Dalla Pozza, Sarah Elitzur, Daniela Silvestri, Franco Locatelli, Anja Moericke, Gernot Engstler, Petr Smisek, Nicole Bodmer, Draga Barbaric, Shai Izraeli, Carmelo Rizzari, Joachim Boos, Barbara Buldini, Claudia Lanvers-Kaminsky, Giovanni Cazzaniga, Bernd Gruhn, Andrea Biondi, Martin Schrappe
Journal: Blood (2022)
Real-World Treatment Patterns of Patients Initiating Third-Line Therapy in Relapsed or Refractory Multiple Myeloma in Europe
Authors: Moritz Lehne, K. Martin Kortuem, Elena Zamagni, Tim d'Estrube, Soham Shukla, Evi Zhuleku, Marco Ghiani, Maya Hanna, Ulf Maywald, Thomas Wilke, Sue Perera
Journal: Blood (2022)
Novel Therapies for De Novo or Relapsed/Refractory AML with TP53 Mutations : A Glimmer of Hope
Authors: Usman Ali Akbar, Ahmed Abdelhaleem, Ramsha Abbas, Abraham Titus, Sooaj Kumar, Aqsa Ashraf, Muhammad Aslam Khan, Mounica Vorla, Sobaan Taj, Abdul Wasay, Jenish Bhandari, Hamza Mehmood Sheikh, Maurish Fatima, Junaid A. Wali, Sindhu Vikash, Mohammad Ebad Ur Rehman, Faiz Anwer
Journal: Blood (2022)
Waldenstrom Macroglobulinemia and the Clinical Implications of Acquired Von Willebrand Syndrome
Authors: Karan Chohan, Saurabh Zanwar, Ronald Go, Jonas Paludo, Carrie A. Thompson, Asher Chanan-Khan, Sikander Ailawadhi, Thomas M. Habermann, Thomas E. Witzig, Morie A Gertz, Stephen M. Ansell, Shaji K Kumar, Rajiv K. Pruthi, William L. Nichols, Prashant Kapoor, Meera Sridharan, Jithma P. Abeykoon
Journal: Blood (2022)
Do Children with Immune Thrombocytopenia Have Cerebral Microbleeds?
Authors: Alice C J Hart, Ana Maria Cabrera, Camelia Vladescu, Sobia Mustafa, Richard Syzdlo, Rocel C. Saputil, Michelle MH Tan, Amna Malik, David Sharp, Pedro Vicente, Albert Busza, Michael Laffan, Anastasia Gontsarova, Adam Waldman, Nichola Cooper
Journal: Blood (2022)
A Phase 1, First-in-Human, Dose-Escalation Study of MGD024, a CD123 x CD3 Bispecific Dart® Molecule, in Patients with Relapsed or Refractory CD123-Positive (+) Hematologic Malignancies
Authors: Eric S. Winer, Michael Maris, Manish R. Sharma, Patrick Kaminker, Enxu Zhao, Ashley Ward, Andrew L. Sochacki
Journal: Blood (2022)
Killer Cell Immunoglobulin-like Receptor Profile in Acute Myeloid Leukemia with Heterogenous Cytogenetic Abnormalities and Its Association with Clinical Outcome
Authors: Fareena Bilwani, Fatima Iqbal, Tariq Moatter, Naureen Allani, Anila Rashid, Munira Moosajee, Mohammad Khurshid
Journal: Blood (2022)
Development of a Comprehensive Program for Evaluation of Hereditary Predisposition to Hematologic Malignancies
Authors: Jennie Vagher, Bryan D. Huber, Luke Maese, Archana M Agarwal, Afaf Osman, Ami B. Patel, Tsewang Tashi, Paul J Shami, Tibor Kovacsovics, Julie D. Asch, Charles J. Parker, Srinivas K. Tantravahi
Journal: Blood (2022)
Absolute Lymphocyte Count Is an Independent Survival Predictor in Patients with Acute Myeloid Leukemia Treated with Intensive Chemotherapy
Authors: Gianluca Cristiano, Jacopo Nanni, Letizia Zannoni, Federico Zingarelli, Chiara Sartor, Sarah Parisi, Stefania Paolini, Cristina Papayannidis, Michele Cavo, Antonio Curti
Journal: Blood (2022)
FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma
Authors: Matthew J. Maurer, Vit K Prochazka, Christopher R. Flowers, Lasse Hjort Jakobsen, Diego Villa, Caroline E. Weibull, Elliot J. Cahn, Alexandra Smith, Herve Ghesquieres, Robert Kridel, Maher Gandhi, Chan Y. Cheah, Eliza Hawkes, John F. Seymour, Ciara L. Freeman, Michael Roost Clausen, Björn E Wahlin, Jonathan W. Friedberg, Carla Casulo, Thomas M. Habermann, Yucai Wang, Loretta J. Nastoupil, Peter De Nully Brown, David Belada, Andrea Janíková, Heidi Mocikova, Tomáš Fürst, Richard Burack, Peter Martin, Jonathon B. Cohen, Izidore S. Lossos, Brad S. Kahl, Brian K. Link, Karin E. Smedby, Laurie H. Sehn, Marek Trneny, Tarec Christoffer Christoffer El-Galaly, James R. Cerhan
Journal: Blood (2022)
Global Seroprevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Serotypes of Relevance to Gene Therapy
Authors: Professor John Rasko, George Bashirians, Christos Petropoulos, Terri Wrin, Yuvika Paliwal, Suryanarayan Somanathan, Michelle Casey, Candida da Fonseca Pereira, Ian Winburn, Amit Chhabra
Journal: Blood (2022)
Efficacy and Safety of IDH Inhibitors in AML: A Systematic Review of Clinical Trials
Authors: Muhammad Ashar Ali, Shadma Fatima, Ashish Nepal, Huda Khan, Mahak Khadija Bhatti, Memoona Saeed, Rabiya Niaz, Rooma Habib, Zainab Omar, Zubair Shafique, Muhammad Imran Khan, Muhammad Hassab, Wajeeha Aiman
Journal: Blood (2022)
ORM-6151: A First-in-Class, Anti-CD33 Antibody-Enabled GSPT1 Degrader for AML
Authors: James Palacino, Pedro Lee, Hangyeol Jeong, Yeonjoon Kim, Yoojin Song, Uttapol Permpoon, Wesley Wong, Chen Bai, Nathan Fishkin, Khuloud Takrouri, Eunjin Yu, Yong Yi, Anna Skaletskaya, Ki-Hwan Chang, Min-Soo Kim, Da-Yeong Kim, Dong-Ki Choi, Peter U Park
Journal: Blood (2022)
A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)
Authors: Ana Maria Avila, Saad Arain, Karen Sweiss, Pritesh Patel, Samin Houshyar, Gregory S Calip, Irum Khan, Paul G. Rubinstein, Chukwuemeka Uzoka, John G. Quigley
Journal: Blood (2022)
PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study
Authors: Hanwen Zhang, Shuhua Wang, Manali Rupji, Chenxi Wu, Sanjay Chandrasekaran, Christopher R. Funk, Patrick J. King, Saketh Kollipara, Ishani Rao, Esohe Ayanru, Julia Duffy, Roberta Kaplow, Aseala Abousaud, Aneesh Mehta, John D. Roback, Daniel Kalman, G. Marshall Lyon, Mark Caridi-Scheible, Gregory Bisson, Yuan Liu, Silvia Coma, Jonathan A. Pachter, Cynthia R. Giver, Edmund K. Waller
Journal: Blood (2022)
A Preliminary Analysis of Athn 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia a or B with Inhibitors
Authors: Tammuella Chrisentery-Singleton, Lauren E. Amos, Daniel Bonzo, Miguel Escobar, Adam Giermasz, Emmanuelle Lagrue, Christine Knoll, Sonia Nasr, Michael Recht, Spencer Sullivan, Doris V. Quon, Mark T. Reding
Journal: Blood (2022)
COVID-19 Infection in Children with Down Syndrome and Hematologic Malignancies
Authors: Blake Foxworthy, Elizabeth C Davis, Ana C. Xavier, Julienne Brackett, David Dickens, Alissa R. Kahn, Isaac Martinez, Archana Sharma, Carla Schwalm, Jessica M. Foley, Jennifer J. Wilkes, Smita Bhatia, Jennifer M Levine, Emily Johnston, Julie A. Wolfson
Journal: Blood (2022)
A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit
Authors: Sung-Eun Lee, Sung-Soo Yoon, Deok-Hwan Yang, Gyeong-Won Lee, Seug Yun Yoon, Sang Kyun Sohn, Ho-Jin Shin, Sung Hwa Bae, Chul Won Choi, Eun-Ji Choi, June-Won Cheong, Soo-Mee Bang, Joon Seong Park
Journal: Blood (2022)
Identification of Novel Antigens for Normal Karyotype Triple Mutated Acute Myeloid Leukemia
Authors: Arnaud Metois, Marie-Eve Bordeleau, Louis Theret, Azadeh Hajmirza, Ossama Moujaber, Jean-François Spinella, Jalila Chagraoui, Nadine Mayotte, Isabel Boivin, Eric Audemard, Azer Farah, Véronique Lisi, Eric Bonneil, Pierre Thibault, Guillaume Richard-Carpentier, Vincent-Philippe Lavallée, Josee Hebert, Philippe P Roux, Guy Sauvageau
Journal: Blood (2022)
Real-World Safety and Efficacy of Gemtuzumab Ozogamicin in Relapsed or Refractory AML
Authors: Ian M. Bouligny, Graeme Murray, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Keri Maher
Journal: Blood (2022)
A Phase 1b Study of IDH Inhibition with Enasidenib and MEK Inhibition with Cobimetinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Who Have Co-Occurring IDH2 and RAS Signaling Gene Mutations
Authors: Brian J Ball, Eytan Stein, Marjorie Robbins, Jianying Zhang, Ross L. Levine, Timothy Synold, Anthony S. Stein, Guido Marcucci, Yilun Liu, Alexey V Danilov
Journal: Blood (2022)
Implementation of Transcranial Doppler Ultrasound Stroke Risk Screening in Urban and Rural Sickle Cell Disease Clinics in Zambia
Authors: Catherine-Chunda Mupela Liyoka, Mwanza Suzanna, Gretchen Birbeck, Lisa Kafula Nkole, Alice Nanyangwe, Clement Lupumpaula, Janet Simanguwa Chilima, Peter Kabemba, Nicole Fortier O'Brien
Journal: Blood (2022)
Integrating High-Throughput Dynamic BH3 Profiling and Molecular Phenotyping to Identify Therapeutic Vulnerabilities in CLL
Authors: Salma Parvin, Binyamin A. Knisbacher, Aditi Aryal, Stacey M. Fernandes, Donna S. Neuberg, Catherine J. Wu, Jennifer R. Brown, Gad Getz, Anthony G. Letai
Journal: Blood (2022)
High Metabolic Tumor Volume Is Associated with Higher Toxicity and Decreased Efficacy of BCMA CAR-T Cell Therapy in Multiple Myeloma
Authors: Ricardo Villanueva, Doris K. Hansen, Rolf Petter Tonseth, Kenneth L Gage, Zhouping Wei, Gabriel De Avila, Rachid C. Baz, Ariel F Grajales-Cruz, Omar Castaneda-Puglianini, Brandon J. Blue, Jason Brayer, Kenneth H. Shain, Melissa Alsina, Hien D. Liu, Taiga Nishihori, Meghan A Menges, Frederick L. Locke, Yoganand Balagurunathan, Ciara L. Freeman
Journal: Blood (2022)
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis
Authors: Erika Morsia, Elena Torre, Francesca Marrara, Sonia Morè, Mauro Petrini, Valentina Maria Manieri, Laura Gurgoglione, Guido Gini, Massimo Offidani, Attilio Olivieri, Serena Rupoli
Journal: Blood (2022)
Molecular Systems Network Predicts Sars-Cov-2 NSP3 and Orf6 Role in COVID-19 Related Thrombotic Events
Authors: Mushtaq Hussain, Fakiha Siddiqui, Syed Muhammad Omer, Anusha Amanullah, Nusrat Jabeen, Bulent Kantarcioglu, Jawed Fareed
Journal: Blood (2022)
Non-Canonical FLT3 Mutations (FLT3m) in Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) - Outcomes and Prognosis after FLT3 Inhibitor (FLT3i) and Venetoclax Based Regimens
Authors: Sai Prasad Desikan, Naval Daver, Sanam Loghavi, Tapan M. Kadia, Nicholas Short, Courtney D. DiNardo, Gautam Borthakur, Sherry A. Pierce, Keyur P. Patel, Hussein A Abbas, Abhishek Maiti, Guillermo Garcia-Manero, Farhad Ravandi, Hagop Kantarjian, Musa Yilmaz
Journal: Blood (2022)
Expansion of Content in the Phenx Toolkit for Sickle Cell Disease Pain
Authors: Stephanie H Guarino, Mark D Nelms, David Williams, Amanda M. Brandow, C. Patrick Carroll, Nitya Bakshi, Claudia M Campbell, Deepika S. Darbari, Martha Kenney, Wally R Smith, Jennifer Stinson, William Zempsky, Wayne Huggins, Deborah Maiese, Tabitha Hendershot, Carol Hamilton
Journal: Blood (2022)
Frailty in Patients Undergoing Chimeric Antigen Receptor T-Cell (CAR T) Therapy at Princess Margaret Cancer Centre: A Prospective Pilot Study
Authors: Anca Prica, Tiana Coley, Rachel Aitken, Abi Vijenthira, Manjula Maganti, Samantha J Mayo, Christine I. Chen, John Kuruvilla, Michael Crump, Sita Bhella, Robert Kridel, Vishal Kukreti, Chloe Yang, Shabbir Alibhai
Journal: Blood (2022)
Presence of Activating STAT3 Mutations in the CD8+ T Cells of Rheumatoid Arthritis Patients
Authors: Katharine B. Moosic, Thomas L. Olson, Mark Freijat, Samara Khalique, Cait E. Hamele, Bryna Shemo, Jesse Boodoo, William Baker, Matthew W. Schmachtenberg, Erika Darrah, Felipe Andrade, Kristine C. Olson, David J. Feith, Donald L. Kimpel, Thomas P. Loughran
Journal: Blood (2022)
Burden of Iron Deficiency and Correlation of Reticulocyte Hemoglobin Content (CHr) in Iron Deficiency-a Study from Tertiary Care Center in Developing Country
Authors: Vaibhav Chadha, Sangeeta Mudaliar, Ritika Khurana, Dhara Shah, Trupti Dhabale, Dhruv Mamtora, Minnie Bodhanwala, Mukesh Manharlal Desai, Bharat Agarwal, Sudha Rao
Journal: Blood (2022)
Comparison of Rivaroxaban and Low Molecular Weight Heparin in the Treatment of Cancer-Associated Venous Thromboembolism
Authors: Craig I. Coleman, Kimberly Snow Caroti, Khaled Abdelgawwad, George Psaroudakis, Marcela Rivera, Gunnar Brobert, Alexander T. Cohen, Alok A. Khorana, Cecilia Becattini, Agnes Y. Lee, Anders Ekbom, Marc Carrier
Journal: Blood (2022)
Long-Term Outcomes in Patients with Idiopathic Portal Venous System Thrombosis (PVST) in a Limited Resource Setting. Should We Do an Extensive Thrombophilia Work-up?
Authors: Fernando Gil López, Fausto Rios Olais, Angel Gabriel Vargas Ruiz, Roberta Demichelis, Frida Ayala Aguillón, Analy Mora Cañas, Jorge Luis Alcazar Ylizaliturri, Juan Rangel-Patiño
Journal: Blood (2022)
HCK Inhibition Displays Antineoplastic Activity on Acute Leukemia and Promotes Immune Regulation of the Bone Marrow Tumor Microenvironment
Authors: Fernanda Marconi Roversi, Maura Lima Pereira Bueno, Audrey Basso, Adriana Silva Santos Duarte, Juliete A.F. Silva, Sara T Olalla Saad
Journal: Blood (2022)
The Impact of Glycemic Control in Thrombo-Inflammatory Biomarkers in Diabetic Pulmonary Embolism Patients
Authors: Bulent Kantarcioglu, Alexander O'Hara, Jacob Pozin, Roumika Patil, Madeline Allen, Emily Krupa, Fakiha Siddiqui, Debra Hoppensteadt, Atul R. Laddu, Amir Darki, Jawed Fareed
Journal: Blood (2022)
Phase I Study of Ruxolitinib in Combination with Abemaciclib for Patients with Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Authors: Jan Philipp Bewersdorf, Srdan Verstovsek, Andriy Derkach, Lucia Masarova, Naveen Pemmaraju, Eytan Stein, Michael Mauro, Raajit K Rampal, Prithviraj Bose
Journal: Blood (2022)
Profile of Perioperative Coagulation in Major Liver Resection for Cancer: A Prospective Observational Study
Authors: Patrick Van Dreden, Petros Tzimas, Eleftheria Lefkou, Agathi Karakosta, Stellios Argyron, Evangelia Papapetrou, Despoina Pantazi, Alexandros Tselepis, Panagiota Stratigopoulou, Georgios Glantzounis, Kallirroi Kalantzi, Grigorios T. Gerotziafas
Journal: Blood (2022)
Bone Marrow WT1 mRNA Upregulation in Acute Myeloid Leukemia (AML) in Complete Molecular Remission (mCR): Understanding the Limitations and Advantages of WT1 As a Measurable Residual Disease (MRD) Target
Authors: Albert Esquirol, Yolanda Guillén, Elena Bussaglia, Vanesa Criado, Maite Carricondo, Pamela Acha, Manel Esteller, Jorge Sierra, Francesc Solé, Anna Bigas, Josep F Nomdedeu
Journal: Blood (2022)
Changes in the Gut Microbial Diversity and Its Correlation with the Clinical Outcome in Children with Acute Myeloid Leukemia (AML) Receiving Induction Chemotherapy
Authors: Mai Adel, Reham Abdelaziz Khedr, Ahmed Elsayed, Lobna Shalaby, Abdelrahman Omar, Aya A. Diab, Mervat Elanany, Leslie E. Lehmann, Alaa Elhaddad
Journal: Blood (2022)
Single-Cell Multiomics of Pre- and Post- Remission Bone Marrow from a Pediatric Patient with JMML Reveal Distinct Progenitors and Inflammatory Monocytes Which Are Eliminated By Chemotherapy
Authors: Rula Green Gladden, Shruti Bhise, Sami B Kanaan, Olivia Waltner, Jeffrey Stevens, Colleen Annesley, Scott N Furlan
Journal: Blood (2022)
Gemtuzumab Ozogamicin for Cytoreduction in Hyperleukocytosis
Authors: Matthew Scarlotta, Jonathan Webster, Matthew Newman, Cory Schulz, Kristin Stokvis, Alexander J. Ambinder, Tania Jain, William Brian Dalton, Lukasz P. Gondek, Gabrielle T. Prince, Gabriel Ghiaur, Christopher S. Hourigan, Amy E. DeZern, Ivana Gojo, Jonathan Allen Webster, Mark J. Levis
Journal: Blood (2022)
Resistance to the Non-Covalent BTK Inhibitor Pirtobrutinib
Authors: Aishath S Naeem, Filippo Utro, Qing Wang, Justin Cha, Mauno Vihinen, Stephen P. Martindale, Yinglu Zhou, Svitlana Tyekucheva, Annette S. Kim, Stacey M. Fernandes, Rayan Fardoun, Gordon Saksena, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P Danysh, Kara Slowik, Raquel Jacobs, Matthew S. Davids, Rula Zain, Edvard CI Smith, Ignaty Leshchiner, Laxmi Parida, Gad Getz, Jennifer R. Brown
Journal: Blood (2022)
Body Composition and Immunonutritional Status Impact Survival Outcomes after CD19 CAR T-Cell Therapy
Authors: Kai Rejeski, David M. Cordas dos Santos, Paul Trinkner, Sophie Guenther, Lian Liu, Michael Winkelmann, Veit L Buecklein, Viktoria Blumenberg, Christian Schmidt, Philipp Karschnia, Wolfgang G. Kunz, Michael von Bergwelt, Sebastian Theurich, Marion Subklewe
Journal: Blood (2022)
Prevalence of Pathogenic Germline Mutations in Solid Tumor Predisposition Genes Detected By Tumor-Normal Whole Exome Sequencing Analysis Among Adults with Hematologic Malignancies
Authors: Hussam Al-Kateb, Tomi Jun, Jim Hayes, Michael Rossi, Feras Hantash, William K. Oh, Kenan Onel
Journal: Blood (2022)
Association of Non-Hodgkin Lymphoma (NHL), Comorbidity and Death Due to Other Cancers in 30,000 Older Adults from SEER-Medicare
Authors: Max J. Gordon, Zhigang Duan, Hui Zhao, Loretta J. Nastoupil, Alessandra Ferrajoli, Alexey V Danilov, Sharon Giordano
Journal: Blood (2022)
In Vitro and In Vivo Studies Support GFH009, a Selective CDK9 Inhibitor, As a Potential Treatment for Hematologic Cancers
Authors: Fusheng Zhou, Lili Tang, Siyuan Le, Mei Ge, Dragan Cicic, Fubo Xie, Jinmin Ren, Jiong Lan, Qiang Lu
Journal: Blood (2022)
Arterial Thromboembolism in Cancer Patients Treated with Apixaban
Authors: Trine-Lise Larsen, Jorunn Brekke, Herish Garresori, Hege Frøen, Eva-Marie Jacobsen, Dag Torfoss, Hilde Skuterud Wik, Tone Ronnaug Enden, Alina Carmen Porojnicu, Petter Quist-Paulsen, Elin Velle, Per Morten Sandset, Anne Hansen Ree, Anders E.A. Dahm
Journal: Blood (2022)
PICC Insertion and Management in Hodgkin and NON-Hodgkin Lymphomas: A 13-YEARS Monocentric Experience
Authors: Daniele Derudas, Maria Pina Simula, Stefania Massidda, Daniela Dessì, Sara Veronica Usai, Giuseppe Longhitano, Daniela Ibba, Loredana Aracu, Giorgio La Nasa
Journal: Blood (2022)
Heparin-Induced Thrombocytopenia Is Associated with Higher in-Hospital Mortality after Left Ventricular Assist Device Placement: A Retrospective Cohort Study from National Inpatient sample2016-2019
Authors: Tejaswi Vinjam, Nischit Baral, Calvin Ghimire, Simi M. Mathew, Raghavendra Akhil Bogabathina, Ujwala Koduru, Arvind Kunadi, Joshua D. Mitchell
Journal: Blood (2022)
Proteomic Profiles of Cytokine Release Syndromes Following Lisocabtagene Maraleucel and Idecabtagene Vicleucel
Authors: Abu-Sayeef Mirza, Alexander Pine, Yusuf Rasheed, Ramzi Hamouche, Etienne Leveille, George Goshua, Sean Gu, Yuxin Liu, Jennifer VanOudenhove, Noffar Bar, Natalia Neparidze, Francine M. Foss, Lohith Gowda, Iris Isufi, Stephanie Halene, Alfred I Lee, Stuart Seropian
Journal: Blood (2022)
Hydroxyurea Use Among Youth with Sickle Cell Anemia across Eight Care Centers within the United States
Authors: Aimee K. Hildenbrand, Daniel Eckrich, Amanda M. Lewis, Corinna L. Schultz, Melissa A. Alderfer, Christopher B. Forrest, Susan E. Creary, Monica L. Hulbert, Suchitra Rao, Dimitri A. Christakis, Lori E. Crosby
Journal: Blood (2022)
Personalized Prediction Model to Risk Stratify Patients with Therapy-Related Myeloid Neoplasms
Authors: Chung Hoow Kok, Elizabeth Ngoc Hoa Tran, Dariusz Ladon, Rakchha Chhetri, Anmol Baranwal, Kirsty M Sharplin, Hassan B. Alkhateeb, Deepak Singhal, Aref Al-Kali, Naseema Gangat, David T Yeung, Mark R. Litzow, David M Ross, William J. Hogan, Ashanka Begna Kebede, Abhishek A. Mangaonkar, Mrinal M. Patnaik, Ayalew Tefferi, Naranie Shanmuganathan, Sharad Kumar, Daniel Thomas, Mithun V. Shah, Devendra Hiwase
Journal: Blood (2022)
Dynamics of Mortality and Transformation Risk within Different Risk Groups of Patients with Myelodysplastic Syndromes Stratified According to the IPSS-R - Comparison of Treated and Untreated Patients and Consequences for the Description of Risk Categories
Authors: Michael Pfeilstocker, Heinz Tuechler, Lionel Ades, Jaroslav Cermak, Fatiha Chermat, Matteo G. Della Porta, Pierre Fenaux, Guillermo Garcia-Manero, Ulrich Germing, Detlef Haase, Andrea Kuendgen, Michael Luebbert, Silvia Maria Meira Magalhaes, Luca Malcovati, Yasushi Miyazaki, Guillermo Sanz, Valeria Santini, Mikkael A. Sekeres, Matthew J Walter, Peter Valent, Peter L Greenberg
Journal: Blood (2022)
Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination
Authors: Saurabh Zanwar, Matthew Ho, Francis K. Buadi, Sikander Ailawadhi, Jeremy T. Larsen, P. Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A. Gertz, Wilson I. Gonsalves, Ronald Go, Suzanne R. Hayman, Prashant Kapoor, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma M Warsame, Amie Fonder, Miriam A. Hobbs, Yi L. Hwa, Robert A. Kyle, S. Vincent Rajkumar, Shaji K Kumar
Journal: Blood (2022)
Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
Authors: Alexandra Pedraza, Paola Charry, Jordi Fornells, Mar De Pablo-Miró, Ares Guardia, Katia Guinetti, Dagmar Marin, Alba Sanchez, Aura Ferrer, Silvia Sauleda, Nuria Martinez, Cristina Sanz
Journal: Blood (2022)
A New Phen X Collection: Sickle Cell Disease Psychosocial and Social Determinants of Health Protocols
Authors: Lori E. Crosby, Allison A. King, Jerlym S. Porter, Sherif M. Badawy, Dominique Bulgin, Steven J. Hardy, Staci D. Arnold, Desiree Williford, Marsha Treadwell, Wayne Huggins, Cataia Ives, Marian Sullivan, Carol Hamilton
Journal: Blood (2022)
Assessing the Relationship between Thrombosis and Immune-Related Adverse Events in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors
Authors: Daniela Arango Isaza, Lauren O'Loughlin, Rushad Patell, Hollis Viray, Donna S. Neuberg, Laura E. Dodge, Deepa Rangachari, Aarti Asnani, Jeffrey I. Zwicker, Daniel Costa
Journal: Blood (2022)
Myelodysplastic Syndromes Presenting with Isolated Thrombocytopenia: A Less Aggressive Form of Presentation and with Better Prognosis
Authors: Marie Solange Flores-Moran, Leonor Arenillas, Ana Ferrer, Felix Lopez-Cadenas, Sara Garcia-Avila, Concepción Fernández, Antonio Salar, Xavier Calvo
Journal: Blood (2022)
Clinical Benefits, Harms, and Cost-Effectiveness of Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Decision Analytic Modelling Study
Authors: Faizan Khan, Doug Coyle, Kednapa Thavorn, Sasha van Katwyk, Tobias Tritschler, Brian Hutton, Gregoire Le Gal, Marc A. Rodger, Dean Fergusson
Journal: Blood (2022)
CD69+ Bone Marrow-Resident CD8+ T Cells Represent a Functionally Impaired Tumor-Reactive Population and Can be Restored By Blocking PD-1 and Tigit in Multiple Myeloma
Authors: Yoon Seok Choi, Yuri Lee, Jun Soung Park, Minsuk Kwon, Seong Hyun Jeong, Jeong Seok Lee, Eui-Cheol Shin, Joon Seong Park
Journal: Blood (2022)
Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of US Claims Data
Authors: Mahek Garg, Ambika Satija, Yan Song, Eric Sarpong, Ben Meade, Esteban Lemus-Wirtz, Katherine Gaburo, James E. Signorovitch, Monika Raut, Katherine Elizabeth Ryland, Samhita Chakraborty
Journal: Blood (2022)
IPSS-M Applicability and Clinical Impact in Decision-Making Process in Real-Life Clinical Practice
Authors: Sandra Novoa Jáuregui, Laura Palomo, Ana Pérez, Bárbara Tazón, Maria Julia Montoro, Adoracion Blanco, Silvia Saumell, Laura Gallur, Eugenia Rivero, Sara Garrido, Marc Bosch Schips, Sofia Laura Muzio, Margarita Ortega, Antonieta Molero Yordi, Francesc Bosch, David Valcárcel
Journal: Blood (2022)